Notícias · Recifes

Commonly used drugs show small benefit for long COVID fatigue

Over-the-counter antihistamines and a prescription anti-inflammatory drug both have a small benefit in reducing long COVID fatigue among people receiving care from specialist long COVID clinics, according to new findings from a large clinical trial led by UCL and UCLH.

Admin Recifes 15/07/2026 2

GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests

GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest that the drugs may offer benefits to another patient popula

Admin Recifes 15/07/2026 3

FDA expands use of first sickle cell disease gene therapy for children as young as 2 years

The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients ages 2 and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent β thalassemia (TDT). Supplement

Admin Recifes 15/07/2026 2

Psychedelic drug screen in mice may overlook stress and brain changes

Over the past decades, some medical researchers and neuroscientists have been exploring the possible therapeutic effects of psychedelic compounds, such as lysergic acid diethylamide (LSD) and psilocybin. These are substances that act on serotonin receptors in the brain and can al

Admin Recifes 15/07/2026 2

New treatment helps achieve a healthier BMI in people with weight dysregulation after brai

A new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found. The results of the trial have been published in the New England Journal of Medicine. The new drug, setmelanotide, offers h

Admin Recifes 15/07/2026 2

New experimental approach may help overcome drug resistance in deadly brain cancer

Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one of the most aggressive forms of brain cancer: resistance to chemotherapy. The study shows that an experimental compound called BA-101 can restore the effective

Admin Recifes 15/07/2026 2

Societies combine to issue recommendations on use of incretin drugs in obesity therapy

Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use of obesity drugs for weight loss treatment. The statement, which is published in The Lancet Diabetes & Endocrinology, is led by Dr. Laurence Dobbie of the

Admin Recifes 15/07/2026 2

GLP-1 use hits record high as Medicare opens access to weight-loss drugs

The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%. O recorte ajuda a contextualizar a pauta dentro de Fitness.

Admin Recifes 15/07/2026 2

New genetic switch could improve gene therapy for drug-resistant epilepsy

Epilepsy affects more than 50 million people worldwide, making it one of the most common neurological disorders. Although medication helps many patients achieve seizure control, approximately one-third continue to experience seizures despite treatment. Seizures often arise when t

Admin Recifes 15/07/2026 2

Health care spending gap between high- and low-income Americans continues to widen, study

A new study led by a University of Chicago researcher finds that health care spending in the United States has increasingly diverged between high- and low-income Americans over the past two decades. The analysis shows that through 2023, spending grew faster for high-income Americ

Admin Recifes 15/07/2026 2

Weight‑loss jabs may create a new kind of yo‑yo dieting

For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after eating, helping people feel fuller and less hungry. Moun

Admin Recifes 15/07/2026 2

Artemisinin resistance is rising in East Africa—leaving anti-malarials at risk of failure

Resistance to the main drug in front-line malaria treatments is becoming more widespread across East Africa, according to new research by Imperial College London. The study, published in The Lancet Infectious Diseases, maps the rise in artemisinin resistance in the region and sug

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes